Last reviewed · How we verify
NCT06213545: Tele patch
Diagnostic Accuracy of Teledermatology in Patch Test Interpretation
NA trial testing In-clinic interpretation in Teledermatology in 108 participants. Completed in 24 November 2024.
2 September 2024
Quick facts
| Lead sponsor | Mahidol University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 108 |
| Start date | 3 April 2024 |
| Primary completion | 2 September 2024 |
| Estimated completion | 24 November 2024 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- In-clinic interpretation
- Photo interpretation
Conditions studied
- Teledermatology — all drugs for Teledermatology →
Sponsor
Mahidol University
Who can join
18 and older, any sex, with Teledermatology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to learn about accuracy of teledermatology in patch test interpretation in patch test\'s patients population. The main question\[s\] it aims to answer are: * Accuracy of teledermatology in patch test interpretation by dermatologist * Accuracy of teledermatology in patch test interpretation by Residency * Accuracy of teledermatology in patch test interpretation by Scitentist * The factors influencing the interpretation of remote dermatologic patch test results from photographs of patients. Participants will * do patch test in Siriraj hospital and come to follow up at 48 hr and 72 hr for interpretation of patch test * take a photo at home and sent the photo to contact clinic via online application or email on the day of 48 hr, 72 hr and 7 days following the interpretation of patch test Researchers will compare in-clinic group and telephoto group to see if the accuracy of patch test interpretation is more or less.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06213545
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Mahidol University trials
Trials by the same sponsor.
- NCT07568496 — Greater Occipital Nerve Block for Migraine With Medication Overuse Headache · NA · not yet recruiting
- NCT07407400 — Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients · Phase 4 · not yet recruiting
- NCT07378501 — Thai Version of the Pediatric Quality of Recovery Score (PedSQoR): Translation and Psychometric Validation Study · not yet recruiting
- NCT07438301 — Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration · not yet recruiting
- NCT07390006 — Enabling Patient-Reported Outcomes Through Innovative Care - ACS (EPIC-ACS) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06213545 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mahidol University
- Last refreshed: 27 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06213545.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing